multiFlux 130 (F00013123); multiFlux 160 (F00013124)— 510(k) K252459

Substantially Equivalent

Fresenius Medical Care Renal Therapies Group, LLC

FDA 510(k) clearance K252459 for multiFlux 130 (F00013123); multiFlux 160 (F00013124), Substantially Equivalent on 2026-02-10. Applicant: Fresenius Medical Care Renal Therapies Group, LLC. Device class: 2.

Summary

Fresenius Medical Care Renal Therapies Group lists multiFlux 130 (F00013123) and multiFlux 160 (F00013124) under product code KDI (Dialyzer, High Permeability With Or Without Sealed Dialysate System). The record doesn't say how the two differ.

Class II, 21 CFR 876.5860. Gastroenterology, Urology is both the classification panel and the review panel, and it came in as a Traditional 510(k).

Fresenius Medical Care filed from Waltham, Massachusetts. The substantially equivalent decision came 189 calendar days after receipt (August 5, 2025 to February 10, 2026).

Clearance details

Applicant
Fresenius Medical Care Renal Therapies Group, LLC
Product code
Product code KDI
Device class
Class 2
Regulation
21 CFR 876.5860
Advisory panel
Gastroenterology, Urology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Waltham, MA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code KDI

view all

More clearances from Fresenius Medical Care Renal Therapies Group, LLC

view all

Adverse events under product code KDI

product code KDI
Death
352
Injury
1,474
Malfunction
12,534
Other
4
Total
14,364

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.